NEW YORK (GenomeWeb News) – Waters has sold $200 million in senior notes in a private placement, it said in a filing with the US Securities and Exchange Commission today.

The firm sold three series of notes in the placement: $100 million of 3.4 percent Series F Senior Notes, due June 30, 2021; $50 million of 3.92 percent Series G Senior Notes, due June 30, 2024; and $50 million of Series H Floating Rate Senior Notes bearing interest at 3 month LIBOR plus 1.25 percent, due June 30, 2024.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.